Cécile Péchaire

Cécile Péchaire has extensive work experience in regulatory affairs across various companies. Cécile currently holds the position of Regulatory Affairs Strategy Leader Director at Galapagos, starting in August 2021. Prior to this, they worked at Sanofi Genzyme as the Global Regulatory Team Lead for Rare Blood Disorders from May 2019 to August 2021. Before joining Sanofi Genzyme, they had roles at Ablynx, where they served as an Associate Director of Regulatory Affairs for Cablivi from July 2018 to August 2021, and as a Senior Manager of Regulatory Affairs for Cablivi from September 2016 to July 2018. Cécile also worked at GSK Vaccines as the Global Product Quality Manager from September 2014 to February 2016 and as the Clinical Regulatory Affairs Manager from March 2008 to August 2014. Earlier in their career, they held the position of Regulatory Affairs Manager at Santen from May 2005 to February 2008. Cécile started their career at Afssaps, where they worked as a Regulatory Assessor for Import/Export from May 2004 to October 2004 and as a Regulatory Assessor for Viral Safety for Biological Products from November 2002 to May 2004. Prior to that, they worked as a Project Manager at EFS from May 2001 to October 2002 and as a Resident in Pharmacy at Hospices Civils de Lyon from May 1999 to April 2001.

Cécile Péchaire completed their Pharmacy degree at UNIVERSITE D'AUVERGNE from 1995 to 1999. Cécile then pursued a Ph.D. in residency Pharmacy at Université Claude Bernard Lyon 1 from 1999 to 2003, specializing in the biomedical and pharmaceutical industry. Additionally, they obtained a Master's degree in an undisclosed field of study from the Institut de management des industries de la santé in 2001-2002. Cécile also completed a post-doctoral program in Blood products and plasma at Pierre and Marie Curie University from 2003 to 2004.